Last update 08 Apr 2025

c-myb AS ODN(Abramson Cancer Center of the University of Pennsylvania)

Overview

Basic Info

Drug Type
ASO
Synonyms
C-myb Antisense Oligodeoxynucleotide(Abramson Cancer Center of the University of Pennsylvania)
Target
Action
inhibitors
Mechanism
c-myb inhibitors(Transcriptional activator Myb inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
Boost your research with our RNA technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Philadelphia chromosome positive chronic myelogenous leukemiaPhase 2
United States
30 Jun 1993
Hematologic NeoplasmsPhase 1
United States
01 Sep 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
Combined antisense oligonucleotides (AS-oligos)
movcugybcl(djdpumhuve) = stccucalub wflipnbjek (ohsocjpdrl )
-
01 May 2006
Random oligonucleotides (Ran oligos)
movcugybcl(djdpumhuve) = smoaehknhk wflipnbjek (ohsocjpdrl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free